API0232126

Lisdexamfetamine Dimesylate

Liraglutide is a GLP-1 receptor agonist, antidiabetic drug.

Product Size

Quantity

Pharm Gradet

Standard

Registration

Inquiry

API Description

API Details

Document

Related Patent Status

CAS No.

608137-33-3
Synonyms

Lisdexamfetamine dimesylate; 608137-33-3; lis-dexamfetamine dimesylate
CHEMBL ID

CHEMBL1201178
Molecule Type

Small molecule
Compound CID

11597697

Molecular Weight (g/mol)

455.6
Molecular Formula

C17H33N3O7S2
InChI

InChI=1S/C15H25N3O.2CH4O3S/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16;2*1-5(2,3)4/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19);2*1H3,(H,2,3,4)/t12-,14-;;/m0../s1
InChIKey

CETWSOHVEGTIBR-FORAGAHYSA-N
SMILES

C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O
IUPAC Name

(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid
Exact Mass (Da)

455.17599275
Monoisotopic Mass (Da)

455.17599275

OUR PRODUCTS